Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-19

FDA Tentative Approval: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

FDA issued tentative approval for Teva Respiratory's supplemental NDA for QVAR REDIHALER (beclomethasone dipropionate HFA). The inhaled corticosteroid is intend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QVAR REDIHALER (Beclomethasone dipropionate HFA)

Snippet

SUPPL TA for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)